THE BAKER ADMINISTRATION recently released its budget proposal for one of their most high-profile issues: drug prices in the Medicaid program. To the surprise of many in the biopharmaceutical industry, there are […]
Prescription drugs
Posted inOpinion
Drug costs at pharmacies lack transparency
AS A PRACTICING PHYSICIAN, nearly every time I write a prescription, I have to ask myself: “Will this patient be able to afford this at the beginning of the calendar […]
Posted inOpinion
E-scripts for opioids save lives
GOV. CHARLIE BAKER recently signed into law a bill to mitigate the state-level effects of the ongoing opioid crisis. Like other such legislative efforts at both the federal and state […]
Posted inOpinion
Middlemen drive up patient drug costs
AS LEADERS OF organizations dealing with two of the most difficult chronic conditions to treat – hemophilia and HIV/AIDS – we consistently hear stories about how patients living with these […]
Posted inOpinion
Cost barriers rise for patients
THERE SEEMS TO be a new story each day about how patients across the country are being treated unfairly by their health insurance company. Chances are, you or someone you […]
Posted inOpinion
Taxpayers clean up Big Pharma’s mess
LAST YEAR, the United States saw a 13 percent increase in drug overdose deaths, from an estimated 60,147 lives lost in 2016, to an estimated 67,944 in 2017. For perspective, […]
Posted inOpinion
Electronic opioid scripts save lives
A HEARING EARLIER this month on Beacon Hill underscored the critical need for Massachusetts-specific solutions to the nation’s opioid crisis. As the Legislature prepares next steps to address this critical […]
Posted inOpinion
Insurers’ ‘fail-first’ drug approach increases pain
WHEN YOU LIVE with debilitating pain it becomes a matter of degrees: How bad is it today? Can I get up and walk? Can I get through a day of […]